Also people have sometimes been quick to denigrate the value of Acromegaly- but actually the main competitor Acromegaly drug is worth $1 billy annually, and MS main competitor is $1.6 billy annually.
So I really don't think Acromegaly is anything to be shunned in terms of market potential. Anyone looking for more sexy should be doing a different web search I think.
Keeping in mind I suspect we have a better product in the pipeline (based on available data) for both MS and Acromegaly than anything else available in terms of dosage efficacy and cost- together, this is an outrageously strong market potential. Still have Asthma, bone marrow an cancer to go!
- Forums
- ASX - By Stock
- PER
- today
today , page-30
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $63.10M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 7.0¢ | $18.29K | 260.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 86804 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 116704 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 86804 | 0.069 |
4 | 134427 | 0.068 |
3 | 224490 | 0.067 |
1 | 15000 | 0.066 |
5 | 52000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 116704 | 2 |
0.073 | 78000 | 1 |
0.075 | 13371 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
Last trade - 11.40am 02/08/2024 (20 minute delay) ? |
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
PER (ASX) Chart |